European Regulation (EU) 2017/745 (Article 27)
The Medical Device Regulation introduces the UDI system through its Article 27. Regulation (EU) 2017/746 applies an equivalent system to in vitro diagnostic devices through its Article 24.
The Implementation Timetable
The obligation to apply the UDI carrier on the label and the packaging was deployed in stages, according to the class of the device. For reusable devices that must carry a marking directly on the product, each deadline is two years later.
| Device class | UDI carrier on the label | Direct marking (reusable) |
|---|
| Class III and implantable | 26 May 2021 | 26 May 2023 |
| Class IIa and IIb | 26 May 2023 | 26 May 2025 |
| Class I | 26 May 2025 | 26 May 2027 |
For in vitro diagnostic devices, the same principle applies with its own timetable: class D, then classes B and C, then class A.
Note: UDI labelling is now mandatory for all classes. The only marking deadline still ahead concerns the direct marking of class I reusable devices, on 26 May 2027.
Eudamed: What Changed on 28 May 2026
Regulation (EU) 2024/1860 introduced a progressive roll-out of Eudamed: each module becomes legally mandatory six months after the publication in the Official Journal of the notice that confirms its full functionality.
Decision (EU) 2025/2371, published on 27 November 2025, declared the first four modules functional: Actors, UDI/Devices registration, Notified bodies and certificates, Market surveillance. Their use is therefore mandatory since 28 May 2026 for all economic operators.
Two deadlines follow directly from this:
- →28 November 2026: devices subject to the registration obligation and already on the market before 28 May 2026 must be registered in Eudamed.
- →28 May 2027: MDR/IVDR certificates issued before 28 May 2026 must have been uploaded into the Certificates module by the notified bodies.
The Vigilance and Clinical investigations modules are still in development. Until they go live, vigilance continues to go through the national systems.
History: From the 2006 Decree to the UDI
Traceability of implantable medical devices has been mandatory in France since the decree of November 2006. With no unique code, facilities used paper traceability or in-house relabelling, methods that were heavy and not very reliable. The UDI is precisely the answer to that problem.
UDI Worldwide: FDA, Canada, Brazil, Japan
The United States were the pioneers with the FDA GUDID database, followed by Canada, Brazil (ANVISA), Japan and Australia. This convergence is driven by IMDRF, the international forum of regulatory authorities.